| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 94.06B | 94.22B | 105.62B | 101.70B | 108.82B | 124.35B |
| Gross Profit | 4.84B | 4.92B | 5.54B | 2.13B | 6.10B | 3.08B |
| EBITDA | 2.73B | 2.84B | 4.58B | 8.49B | 3.85B | 7.25B |
| Net Income | 4.03B | 3.92B | 3.92B | 4.22B | 4.08B | 3.71B |
Balance Sheet | ||||||
| Total Assets | 79.72B | 78.38B | 77.20B | 75.89B | 78.50B | 74.30B |
| Cash, Cash Equivalents and Short-Term Investments | 14.49B | 17.02B | 13.47B | 13.96B | 16.54B | 14.50B |
| Total Debt | 11.15B | 11.67B | 11.61B | 12.66B | 15.55B | 14.96B |
| Total Liabilities | 35.31B | 33.89B | 35.15B | 35.77B | 41.57B | 39.25B |
| Stockholders Equity | 41.61B | 41.31B | 39.57B | 37.80B | 34.87B | 33.10B |
Cash Flow | ||||||
| Free Cash Flow | 3.34B | 3.68B | 2.56B | 2.23B | 3.56B | 2.72B |
| Operating Cash Flow | 4.96B | 5.29B | 4.11B | 3.84B | 5.12B | 4.16B |
| Investing Cash Flow | 2.24B | 2.20B | 207.39M | 210.02M | 1.02B | 472.79M |
| Financing Cash Flow | -4.37B | -4.07B | -4.74B | -6.70B | -4.60B | -1.61B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | HK$46.43B | 7.99 | 9.97% | 6.39% | -8.51% | 9.94% | |
75 Outperform | HK$102.96B | 9.94 | 7.51% | ― | 18.89% | 6.97% | |
74 Outperform | HK$152.04B | 11.17 | 14.02% | 3.05% | 11.02% | 4.17% | |
67 Neutral | HK$201.94B | 14.10 | 11.49% | 2.77% | 10.09% | 7.87% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | HK$12.20B | 4.20 | 8.00% | 3.55% | -3.33% | -8.42% | |
58 Neutral | HK$89.87B | 25.39 | 5.53% | ― | 18.42% | 97.52% |